3.0.0 4087 2019-11-15T21:15:50Z 2019-11-15T21:15:50Z House H HR 2012-02-24 112 From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. MARKEY:H.R. 4087.Congress has the power to enact this legislation pursuantto the following:Article 1 Section 8.[Page H950]]]> hsif00 Energy and Commerce Committee House Standing Referred to 2012-02-24T15:00:22Z Food and Drug Administration Safety and Innovation Act 112 2516 S 2012-05-07 Placed on Senate Legislative Calendar under General Orders. Calendar No. 389. Related bill CRS Food and Drug Administration Safety and Innovation Act 112 3187 S 2012-07-09 Became Public Law No: 112-144. Related bill CRS 2012-02-24 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2012-02-24 Introduced in House IntroReferral Intro-H 9 Library of Congress 2012-02-24 Introduced in House IntroReferral 1000 9 Library of Congress M000133 Rep. Markey, Edward J. [D-MA-7] Edward Markey D MA J. 7 N R000435 Rep. Ros-Lehtinen, Ileana [R-FL-18] ILEANA ROS-LEHTINEN R FL 18 2012-02-29 False M000933 Rep. Moran, James P. [D-VA-8] JAMES MORAN D VA P. 8 2012-02-29 False S000510 Rep. Smith, Adam [D-WA-9] ADAM SMITH D WA 9 2012-03-28 False C001049 Rep. Clay, Wm. Lacy [D-MO-1] WM. CLAY D MO LACY 1 2012-03-28 False R000582 Rep. Roe, David P. [R-TN-1] David Roe R TN P. 1 2012-03-28 False S001175 Rep. Speier, Jackie [D-CA-12] Jackie Speier D CA 12 2012-03-28 False B001278 Rep. Bonamici, Suzanne [D-OR-1] Suzanne Bonamici D OR 1 2012-03-28 False P000523 Rep. Price, David E. [D-NC-4] DAVID PRICE D NC E. 4 2012-05-08 False M000312 Rep. McGovern, James P. [D-MA-3] JAMES MCGOVERN D MA P. 3 2012-05-08 False C001069 Rep. Courtney, Joe [D-CT-2] Joe Courtney D CT 2 2012-08-02 False Health Advisory bodies Consumer affairs Disability and paralysis Government information and archives Government studies and investigations Health information and medical records Prescription drugs Health 00 2012-02-24 Introduced in House 2012-06-21T14:31:25Z Prescription Drug Labeling Promotion Act of 2012 - Directs the Secretary of Health and Human Services (HHS) to establish a working group to develop best practices on access to prescription drug labeling for the visually impaired.

Requires the working group to: (1) include equal representation of consumer and industry advocates; (2) promulgate guidance on best practices for pharmacies to ensure that blind and visually impaired individuals have safe, consistent, reliable, and independent access to the information in the labeling of prescription drugs; (3) consider the use of Braille, specified auditory means, and enhanced visual means to provide such access; and (4) consider whether there are technical, financial, manpower, or other factors that may fundamentally impact the ability of pharmacies with 20 or fewer retail locations to implement the best practices.

Directs the Commissioner of Food and Drugs (FDA) to conduct an informational and educational program to inform the public and pharmacists about such guidance and practices.

Directs the Comptroller General: (1) 18 months after such guidance and practices are published, to review pharmacy compliance and the extent to which access barriers continue; and (2) by September 30, 2016, to report on such review, including recommendations for reducing such barriers.

]]> Prescription Drug Labeling Promotion Act of 2012 Short Titles as Introduced Prescription Drug Labeling Promotion Act of 2012 Display Title Prescription Drug Labeling Promotion Act of 2012 Official Title as Introduced To provide for the development and dissemination of best practices to ensure that visually-impaired and blind individuals in the United States have safe, consistent, reliable, and independent access to the information in prescription drug labeling. Introduced in House 2012-02-24T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-112hr4087ih/xml/BILLS-112hr4087ih.xml 2012-02-24 Referred to the House Committee on Energy and Commerce. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.